Sun Pharmaceuticals reported INR117.6B in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aspen Pharmacare APN:SJ 14.82B 758M
Bharat Petroleum BPCL:IN 1186.86B 44.07B
Cipla CIPLA:IN 48.58B 3.63B
Dr.Reddys Laboratories DRRD:IN 53.17B 9B
Jiangsu Hengrui Me. 600276:CH 4.11B 2B
Reliance Infra RELI:IN 1885.22B 221.1B
Sh Fosun Pharma 600196:CH 9.49B 856.29M
Sun Pharmaceuticals SUNP:IN IR 117596.3M 39598.1M
UPL UPLL:IN 130.79B 37.94B